Updated on 19 October 2026
Organs-on-Chip and Microphysiological Systems
Funding Manager Health at imec
Leuven, Belgium
About
Technology blocks like microfluidics, high-density electrodes, biosensors, lens-free imaging and data analytics allow for highly detailed single-cell prediction of human responses.
Imec is actively looking for partners to further finetune our organ-on-chip models towards specific applications. Please see below, the activities imec could cover for the selected Health 2027 call topics.
-
HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment
The call asks for preclinical in vitro models to access the functional effects of tumour temporal heterogeneity on disease initiation, progression and relapse
-
HORIZON-HLTH-2027-01-CARE-02 - Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
The call ask for in-vitro models for adverse drug reaction.
Topic
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Frank Moriarty
Associate Professor of Pharmacoepidemiology at RCSI University of Medicine and Health Sciences
Dublin, Ireland
Project cooperation
Partnering to Prevent Polypharmacy Adverse Drug Reactions via Personalized Care
- Partner seeks Consortium/Coordinator
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Inés Martín
European Project Coordinator at Biokeralty Research Institute AIE
Vitoria, Spain
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Abdulkadir Kayıklı
Founder at Finakis
Istanbul, Türkiye